SIGI
BNTX icon

Susquehanna International Group (Ireland)’s BioNTech BNTX Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$298K – 60
2022
Q2 		$298K Sell
2,000
-2,088
-51% -$319K 0.07% 61
2022
Q1 		$697K Buy
+4,088
New +$687K 0.24% 39

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Susquehanna International Group (Ireland)'s BNTX Position: Q3 2022 in Review

Susquehanna International Group (Ireland) sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 2,000 shares — an estimated $298K sold.

Susquehanna International Group (Ireland) first reported a position in BNTX in Q1 2022 and held it in 2 quarters. The position peaked at $697K in Q1 2022. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • Susquehanna International Group (Ireland) reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 2,000 BioNTech shares in Q3 2022, an estimated $298K.
  • Susquehanna International Group (Ireland) first reported a position in BioNTech in Q1 2022 and held it in 2 quarters.
  • Susquehanna International Group (Ireland)'s BioNTech position peaked at $697K in Q1 2022.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2022, filed 14 Nov 2022.